Survival Prediction Models for Metastatic Bone Disease: A Comprehensive Review of Development, External Validation, and Clinical Applicability
Orthopaedic Surgery · 17.11.2026
DOI: 10.1111/os.70463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Orthopaedic Surgery, online erschienen am 17.11.2026. Verfasst von Tingyu Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.
Abstract (Originalsprache)
Accurate survival estimation fundamentally guides treatment strategy for metastatic bone disease, balancing durable surgical reconstruction against palliative care. Over three decades, predictive tools have evolved from static classical scores into sophisticated nomograms and machine learning algorithms, integrating patient reserve, tumor biology, metastatic burden, and treatment context. In this comprehensive review, we systematically searched PubMed, Embase, and Web of Science and identified 25 studies reporting the development or external validation of multivariable survival prediction models, encompassing classical scoring systems (Tokuhashi, Tomita, Bauer, Katagiri), nomograms (SORG), Bayesian networks (PATHFx), and machine learning algorithms (SORG‐MLA, BMETS). While this methodological evolution improved individualized prognostication in derivation cohorts, external validation studies reveal a critical disconnect: algorithmic complexity does not guarantee clinical transportability. Our synthesis identifies several recurrent sources of this transportability failure, primarily temporal calibration drift from evolving systemic therapies, anatomic site mismatches between spinal and appendicular disease, and selection biases inherent to surgical versus radiotherapeutic cohorts. Consequently, a substantial gap persists between methodological sophistication and actual bedside applicability, and routine clinical deployment of these tools remains premature until these foundational deficits are systematically addressed. Bridging this gap requires shifting from universal prediction tools toward context‐specific, prospectively validated models with routine temporal recalibration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Model Worker and Craftsman Talent Innovation Workshop of Sichuan Province, Chengdu, Sichuan, China.
- Operating Room, Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Tingyu Lin, Linyun Tan, Wacili Da
Förderung
- National Natural Science Foundation of China
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
Zitieren
APA
Lin, T., Wang, Q., Tan, L., Da, W., & Min, L. (2026). Survival Prediction Models for Metastatic Bone Disease: A Comprehensive Review of Development, External Validation, and Clinical Applicability. Orthopaedic Surgery. https://doi.org/10.1111/os.70463
Vancouver
Lin T, Wang Q, Tan L, Da W, Min L. Survival Prediction Models for Metastatic Bone Disease: A Comprehensive Review of Development, External Validation, and Clinical Applicability. Orthopaedic Surgery. 2026. doi:10.1111/os.70463
BibTeX
@article{Lin2026,
author = {Lin, Tingyu and Wang, Quanfeng and Tan, Linyun and Da, Wacili and Min, Li},
title = {Survival Prediction Models for Metastatic Bone Disease: A Comprehensive Review of Development, External Validation, and Clinical Applicability},
journal = {Orthopaedic Surgery},
year = {2026},
doi = {10.1111/os.70463}
}
EUVIMED